Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Sees Large Drop in Short Interest

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) was the target of a large decline in short interest in June. As of June 15th, there was short interest totaling 142,536 shares, a decline of 36.8% from the May 31st total of 225,427 shares. Based on an average daily volume of 897,604 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.0% of the shares of the stock are short sold.

Analyst Ratings Changes

A number of brokerages recently weighed in on CLPBY. Kepler Capital Markets upgraded shares of Coloplast A/S to a “strong-buy” rating in a report on Wednesday, May 20th. The Goldman Sachs Group cut Coloplast A/S from a “hold” rating to a “strong sell” rating in a report on Tuesday, April 7th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold”.

Coloplast A/S Trading Up 5.0%

OTCMKTS CLPBY traded up $0.29 on Thursday, hitting $6.06. 64,311 shares of the company were exchanged, compared to its average volume of 561,154. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.75 and a quick ratio of 1.09. Coloplast A/S has a twelve month low of $5.64 and a twelve month high of $10.03. The firm has a market capitalization of $13.66 billion, a P/E ratio of 43.29, a price-to-earnings-growth ratio of 1.80 and a beta of 0.22. The company’s 50 day moving average price is $6.13 and its 200-day moving average price is $7.19.

Coloplast A/S (OTCMKTS:CLPBY) last announced its earnings results on Tuesday, May 12th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.09 by $0.01. The company had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.11 billion. Coloplast A/S had a net margin of 7.46% and a return on equity of 33.15%. Analysts predict that Coloplast A/S will post 0.4 earnings per share for the current fiscal year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.